discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V₁A receptor antagonists

The discovery of a novel series of 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamide antagonists of the vasopressin V₁A receptor is disclosed. Compounds 47 and 48 were found to be high affinity, selective vasopressin V₁A antagonists.

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 21; no. 10; pp. 3163 - 3167
Main Authors Napier, Susan, Wishart, Grant, Arbuckle, William, Baker, James, Barn, David, Bingham, Matilda, Brown, Angus, Byford, Alan, Claxton, Chris, Craighead, Mark, Buchanan, Kirsteen, Fielding, Lee, Gibson, Lindsay, Goodwin, Richard, Goutcher, Susan, Irving, Nicholas, MacSweeney, Cliona, Milne, Rachel, Mort, Chris, Presland, Jeremy, Sloan, Hazel, Thomson, Fiona, Turnbull, Zara, Young, Trevor
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 15.05.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The discovery of a novel series of 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamide antagonists of the vasopressin V₁A receptor is disclosed. Compounds 47 and 48 were found to be high affinity, selective vasopressin V₁A antagonists.
Bibliography:http://dx.doi.org/10.1016/j.bmcl.2011.02.096
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2011.02.096